Literature DB >> 4764368

Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man.

C Harvengt, J P Desager.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4764368     DOI: 10.1007/bf00561796

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  13 in total

1.  CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.

Authors:  S A HASHIM; T B VANITALLIE
Journal:  JAMA       Date:  1965-04-26       Impact factor: 56.272

2.  On the quantitative estimation of prothrombin.

Authors:  A J QUICK
Journal:  Am J Clin Pathol       Date:  1945-12       Impact factor: 2.493

3.  The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.

Authors:  J R Ryan; A Jain
Journal:  J Clin Pharmacol New Drugs       Date:  1972-07

4.  Lignin: a bile-salt sequestrating agent.

Authors:  M A Eastwood; R H Girdwood
Journal:  Lancet       Date:  1968-11-30       Impact factor: 79.321

5.  Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man.

Authors:  K J Hahn; W Eiden; M Schettle; M Hahn; E Walter; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

6.  Digitalis intoxication. Treatment with a new steroid-binding resin.

Authors:  G Bazzano; G S Bazzano
Journal:  JAMA       Date:  1972-05-08       Impact factor: 56.272

7.  Interaction of warfarin and nonsystemic gastrointestinal drugs.

Authors:  D S Robinson; D M Benjamin; J J McCormack
Journal:  Clin Pharmacol Ther       Date:  1971 May-Jun       Impact factor: 6.875

Review 8.  Regulation of cholesterol metabolism. I.

Authors:  J M Dietschy; J D Wilson
Journal:  N Engl J Med       Date:  1970-05-14       Impact factor: 91.245

9.  Rapid fluorometric assay for plasma warfarin.

Authors:  M Corn; R Berberich
Journal:  Clin Chem       Date:  1967-02       Impact factor: 8.327

10.  Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (marcoumar) in the plasma when tested in normal cases and under the influence of drugs.

Authors:  K Seiler; F Duckert
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31
View more
  3 in total

1.  Lack of pharmacokinetic interaction of colestipol and fenofibrate in volunteers.

Authors:  C Harvengt; J P Desager
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

Review 2.  Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 3.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.